Galectin Therapeutics Inc.

This study tested whether a drug called belapectin could prevent the development of esophageal varices—dangerous, swollen veins in the esophagus—in people with advanced liver scarring (cirrhosis) caused by NASH. It involved 357 adults who had cirrhosis but did not yet have these …